Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438592 · ClinicalTrials.gov registry record
PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 924
- Enrollment target
NCT02438592: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02438592 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 924 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02438592 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 924 participants
- Enrollment target
Study Summary
This is an observational study involving retrospective and prospective medical record review covering a total maximum of 104 weeks (24 months) per subject. An Audio Computer- Assisted Self-Interview (ACASI) at study entry will assess demographic and psychosocial variables of study subjects. Data will also be collected to assess clinic level variables. Definitions of engagement, prescription of antiretroviral therapy (ART), and viral suppression in the Continuum of Care (CoC) will utilize common definitions including those by U.S. Department of Health and Human Services (DHHS) and Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB). Data will be collected in a large, simple trial design manner to provide all elements for both the primary and secondary outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 924 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-02 |
What the finished NCT02438592 record still lists
NCT02438592 is an observational study that tracks outcomes without assigning an intervention. The registered 924 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02438592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02438592 about?
NCT02438592 is a clinical study titled "PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders". This is an observational study involving retrospective and prospective medical record review covering a total maximum of 104 weeks (24 months) per subject. An Audio Computer- Assisted Self-Interview (ACASI) at study entry will assess demographic and psychosocial variables of study subjects. Data wil...
What is the current status of trial NCT02438592?
This trial is currently completed. The enrollment target is 924 participants. The study started on 2015-03. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT02438592?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04692493 · 924 participants · Phase 3
Ra-pro Pragmatic Trial
- NCT05656807 · 924 participants · NA
Evaluation of Child Care Staff Weight Management Program
- NCT06082453 · 924 participants · NA
Modernizing Perinatal Syphilis Testing
- NCT03995082 · 925 participants · NA
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia